CHRONIC NEUTROPHILIC LEUKEMIA
Clinical trials for CHRONIC NEUTROPHILIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC NEUTROPHILIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC NEUTROPHILIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: CHRONIC NEUTROPHILIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 11:51 UTC
-
New drug cocktail shows promise for Hard-to-Treat leukemia
Disease control OngoingThis study tests a combination of three drugs (azacitidine, venetoclax, and pevonedistat) in adults with a newly diagnosed, aggressive form of acute myeloid leukemia (AML) that is either related to prior cancer treatment or developed from other blood disorders. The goal is to fin…
Matched conditions: CHRONIC NEUTROPHILIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
New hope for rare blood cancers? fedratinib trial underway
Disease control OngoingThis study tests a drug called fedratinib in 25 adults with rare blood cancers (MDS/MPN and CNL). The goal is to see if it can shrink enlarged spleens and improve blood counts. Participants take the drug by mouth and are monitored for response and side effects.
Matched conditions: CHRONIC NEUTROPHILIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 08, 2026 12:02 UTC